Cargando…

Some natural hypomethylating agents in food, water and environment are against distribution and risks of COVID-19 pandemic: Results of a big-data research

OBJECTIVE: This study analyzes the effects of lifestyle, nutrition, and diets on the status and risks of apparent (symptomatic) COVID-19 infection in Iranian families. MATERIALS AND METHODS: A relatively extensive questionnaire survey was conducted on more than 20,000 Iranian families (residing in m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Besharati, Mohammad Reza, Izadi, Mohammad, Talebpour, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482712/ https://www.ncbi.nlm.nih.gov/pubmed/36186929 http://dx.doi.org/10.22038/AJP.2022.19520

Ejemplares similares

COVID and nutrition: A machine learning perspective
por: Jafari, Nafiseh, et al.
Publicado: (2022)

Clinical Results of Hypomethylating Agents in AML Treatment
por: Cruijsen, Marjan, et al.
Publicado: (2014)

Effect of Tannin-Binding Agents (Polyethylene Glycol and Polyvinylpyrrolidone) Supplementation on In Vitro Gas Production Kinetics of Some Grape Yield Byproducts
por: Besharati, Maghsoud, et al.
Publicado: (2011)

The use of hypomethylating agents in hematologic malignancies: treatment preferences and results
por: Serin, Istemi, et al.
Publicado: (2021)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
por: Xu, Qing-Yu, et al.
Publicado: (2020)

Effects of laparoscopic gastric plication (LGP) in patients with type 2 diabetes, one year follow-up
por: Talebpour, Mohammad, et al.
Publicado: (2015)

Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter
por: Kordella, Chryssoula, et al.
Publicado: (2021)

Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
por: Saliba, Antoine N., et al.
Publicado: (2021)

Management of myelodysplastic syndromes after failure of response to hypomethylating agents
por: Gil-Perez, Angela, et al.
Publicado: (2019)

Treatment of Low-Blast Count AML using Hypomethylating Agents
por: De Bellis, Eleonora, et al.
Publicado: (2017)

Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents
por: Malkaram, Sridhar A, et al.
Publicado: (2022)

PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS.
por: Saavedra, Minerva Montalvo, et al.
Publicado: (2023)

“Big Food,” the Consumer Food Environment, Health, and the Policy Response in South Africa
por: Igumbor, Ehimario U., et al.
Publicado: (2012)

Some Uses of Water as a Therapeutic Agent
por: Stockard, C. C.
Publicado: (1893)

Genome‐wide DNA hypomethylation shapes nematode pattern‐triggered immunity in plants
por: Atighi, Mohammad Reza, et al.
Publicado: (2020)

Efficacy of some natural compounds as antifungal agents
por: Vengurlekar, Sudha, et al.
Publicado: (2012)

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
por: Livio, Pagano, et al.
Publicado: (2018)

Oral Hypomethylating Agents for Myelodysplastic Syndromes: Highlights From SOHO 2020
Publicado: (2021)

A machine learning model of response to hypomethylating agents in myelodysplastic syndromes
por: Radakovich, Nathan, et al.
Publicado: (2022)

Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment
por: Gbolahan, Olumide Babajide, et al.
Publicado: (2017)

A Comparative Study upon the Therapeutic Indices of Some Natural and Synthetic Anti-inflammatory Agents
por: Khodadadi, Ali, et al.
Publicado: (2011)

Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
por: Takahashi, Koichi, et al.
Publicado: (2016)

No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
por: Sohn, Sang Kyun, et al.
Publicado: (2018)

Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
por: Sharma, Anup, et al.
Publicado: (2017)

Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Wong, Kah Keng, et al.
Publicado: (2021)

Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy
por: Nathan, Daniel I., et al.
Publicado: (2020)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
por: Sorrentino, Vincent G., et al.
Publicado: (2021)

Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy
por: Singh, Ratnakar, et al.
Publicado: (2021)

Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes
por: Abbas, Hussein A., et al.
Publicado: (2021)

Curse and blessing: upregulation of oncogenes upon treatment with hypomethylating agents in myelodysplastic syndrome
por: Grimm, Juliane, et al.
Publicado: (2022)

Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome
por: Komrokji, Rami S., et al.
Publicado: (2022)

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma
por: Provez, Lien, et al.
Publicado: (2023)

Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid
por: Chu, Yu-Hsin, et al.
Publicado: (2023)

Twelve year experience of laparoscopic gastric plication in morbid obesity: development of the technique and patient outcomes
por: Talebpour, Mohammad, et al.
Publicado: (2012)

Natural antioxidants from some fruits, seeds, foods, natural products, and associated health benefits: An update
por: Rahaman, Md. Mizanur, et al.
Publicado: (2023)

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
por: Jueliger, Simone, et al.
Publicado: (2016)

Big Tobacco, Big Food, Big Alcohol “Lifestyle Diseases”
por: Damle, S. G.
Publicado: (2018)

Design and Protection Strategy of Distributed Intrusion Detection System in Big Data Environment
por: Chen, Rong
Publicado: (2022)

Big data: Some statistical issues
por: Cox, D.R., et al.
Publicado: (2018)

Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy
por: Kwon, Yong-Rim, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_odnlu52f6etkdab3euoo7boitp